Tamoxifen to help testosterone return after hormone therapy
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study tests whether tamoxifen, a pill that blocks estrogen, can help your testosterone levels recover faster after you finish hormone therapy for prostate cancer. It may reduce side effects like fatigue and low sex drive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have prostate cancer.
- You have completed hormone therapy (ADT) for 6 months or 18-36 months, and have not had any for at least 3 months.
- Your testosterone is very low (below 50 ng/dL) at the start of the study.
- You are able to be up and about (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.
This study tests whether a supervised exercise program can help manage side effects like fatigue and muscle loss when starting hormone therapy for prostate cancer. Participation may improve your quality of life during treatment.
This trial tests a short course of hormone therapy (androgen deprivation therapy) for men with a certain type of prostate cancer that is considered high-risk. The goal is to see if a shorter treatment period can still control the cancer while reducing side effects.
This trial compares two ways of giving hormone therapy (apalutamide) along with radiation after prostate removal surgery. It aims to see which approach helps maintain quality of life while controlling cancer.
This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.
This study tests whether taking a drug called apalutamide (combined with hormone therapy) after prostate removal helps prevent the cancer from returning. It is for men whose prostate cancer has a high risk of coming back after surgery.
Hear when a new Hypogonadism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.